Start learning →

Why do pharma valuers also estimate expiring patents?

ATo cut audit fees
BTo set share face value
CTo fix dividend rate
DTo gauge revenue impact
Answer & Solution
Correct answer: D. To gauge revenue impact
Patent expiry erodes existing revenue streams, so its impact is estimated alongside the pipeline value.
Practise this question with Quill — CA Final →

Keep practising Valuation (Finance)

Browse all Valuation (Finance) questions for CA Final, or explore more Strategicfinancialmanagement topics.

Start a Valuation (Finance) lesson →
Related questions